{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:18:36Z","timestamp":1793161116140,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Millennium Pharmaceuticals, Inc."},{"name":"Instituto de Salud Carlos III of Spain","award":["PI1100464"],"award-info":[{"award-number":["PI1100464"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.expneurol.2013.12.020","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T09:46:38Z","timestamp":1389087998000},"page":"165-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Treatment with anti-TNF alpha protects against the neuropathy induced by the proteasome inhibitor bortezomib in a mouse model"],"prefix":"10.1016","volume":"253","author":[{"given":"Albert","family":"Al\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Bruna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Morell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helgi","family":"van de Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Monbaliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Udina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2013.12.020_bb0005","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/ijc.20287","article-title":"IL-6 as an intracrine growth factor for renal carcinoma cell lines","volume":"111","author":"Alberti","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0010","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/cncr.22921","article-title":"Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature","volume":"110","author":"Badros","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0015","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1470-2045(10)70206-0","article-title":"Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65\/GMMG-HD4 trial","volume":"11","author":"Broyl","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0025","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.expneurol.2010.02.006","article-title":"Neurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in mice","volume":"223","author":"Bruna","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1529-8027.2011.00346.x","article-title":"Evaluation of pre-existing neuropathy and bortezomib retreatment as risk factors to develop severe neuropathy in a mouse model","volume":"16","author":"Bruna","year":"2011","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0030","doi-asserted-by":"crossref","first-page":"e72995","DOI":"10.1371\/journal.pone.0072995","article-title":"Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse","volume":"8","author":"Carozzi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12640-009-9086-1","article-title":"Bortezomib induces the formation of nuclear poly(A) RNA granules enriched in Sam68 and PABPN1 in sensory ganglia neurons","volume":"17","author":"Casafont","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0040","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1172\/JCI39065","article-title":"The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans","volume":"119","author":"Charles","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0045","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood.V87.3.1104.bloodjournal8731104","article-title":"Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B","volume":"87","author":"Chauhan","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.aanat.2011.02.011","article-title":"Wallerian degeneration and peripheral nerve conditions for both axonal regeneration and neuropathic pain induction","volume":"193","author":"Dubovy","year":"2011","journal-title":"Ann. Anat."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0055","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s10571-006-9006-3","article-title":"Intra- and extraneuronal changes of immunofluorescence staining for TNF-alpha and TNFR1 in the dorsal root ganglia of rat peripheral neuropathic pain models","volume":"26","author":"Dubovy","year":"2006","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/FPC.0b013e3283436b45","article-title":"Genetic variation associated with bortezomib-induced peripheral neuropathy","volume":"21","author":"Favis","year":"2011","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0065","doi-asserted-by":"crossref","first-page":"526","DOI":"10.55782\/ane-2008-1720","article-title":"Pro-inflammatory cytokine TNF-alpha as a neuroprotective agent in the brain","volume":"68","author":"Figiel","year":"2008","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0070","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/jcb.240530408","article-title":"TGF-beta 1 is an organizer of responses to neurodegeneration","volume":"53","author":"Finch","year":"1993","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0075","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1200\/JCO.2006.07.9665","article-title":"Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma","volume":"24","author":"Fisher","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0080","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1083\/jcb.201210077","article-title":"Development of proteasome inhibitors as research tools and cancer drugs","volume":"199","author":"Goldberg","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2013.12.020_bb6000","first-page":"187","article-title":"Histologic assessment of sciatic nerve regeneration following resection and graft or tube repair in the mouse","volume":"10","author":"G\u00f3mez","year":"1996","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0085","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1038\/sj.onc.1204623","article-title":"The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications","volume":"20","author":"Hideshima","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0090","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/blood-2009-01-199604","article-title":"Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells","volume":"114","author":"Hideshima","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0095","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.4049\/jimmunol.154.8.4091","article-title":"Effect of IL-6 receptor antisense oligodeoxynucleotide on in vitro proliferation of myeloma cells","volume":"154","author":"Keller","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0100","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/glia.20894","article-title":"Proteasome inhibition suppresses Schwann cell dedifferentiation in vitro and in vivo","volume":"57","author":"Lee","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0105","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ejpain.2008.09.009","article-title":"Tumor necrosis factor receptor 1 induces interleukin-6 upregulation through NF-kappaB in a rat neuropathic pain model","volume":"13","author":"Lee","year":"2009","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-2094-7-27","article-title":"TNF-alpha and neuropathic pain\u2014a review","volume":"7","author":"Leung","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0115","doi-asserted-by":"crossref","first-page":"16096","DOI":"10.1074\/jbc.M109.072694","article-title":"Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IkappaB(alpha) degradation","volume":"285","author":"Li","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0125","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2567.2006.02433.x","article-title":"Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus","volume":"119","author":"Liang","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-9255-6-10","article-title":"Evaluation of anti-IL-6 monoclonal antibody therapy using murine type II collagen-induced arthritis","volume":"6","author":"Liang","year":"2009","journal-title":"J. Inflamm. (Lond.)"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0135","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3324\/haematol.12106","article-title":"Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression","volume":"93","author":"Mateos","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0140","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-540-79090-7_12","article-title":"Cytokine and chemokine regulation of sensory neuron function","volume":"417\u2013449","author":"Miller","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/1073858412444007","article-title":"NF-kappaB signaling pathways: role in nervous system physiology and pathology","volume":"19","author":"Mincheva-Tasheva","year":"2013","journal-title":"Neuroscientist"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0160","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1529-8027.2011.00362.x","article-title":"The ology of neuropathy: an integrative review of the role of neuroinflammation and TNF-alpha axonal transport in neuropathic pain","volume":"16","author":"Myers","year":"2011","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1359-6446(05)03637-8","article-title":"The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets","volume":"11","author":"Myers","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/exnr.1994.1163","article-title":"Comparison of regenerative and reinnervating capabilities of different functional types of nerve fibers","volume":"129","author":"Navarro","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jnr.490410113","article-title":"Innervation of cutaneous structures in the mouse hind paw: a confocal microscopy immunohistochemical study","volume":"41","author":"Navarro","year":"1995","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0180","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1200\/jco.2012.30.15_suppl.8018","article-title":"Phase II, randomized, double blind, placebo controlled study comparing siltuximab plus bortezomib versus bortezomib alone in patients with relapsed\/refractory multiple myeloma","volume":"30","author":"Orlowski","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0185","article-title":"Proteasome inhibition induces DNA damage and reorganizes nuclear architecture and protein synthesis machinery in sensory ganglion neurons","author":"Palanca","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0190","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4161\/cc.7.7.5625","article-title":"Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells: a possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibition","volume":"7","author":"Poruchynsky","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0195","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa030288","article-title":"A phase 2 study of bortezomib in relapsed, refractory myeloma","volume":"348","author":"Richardson","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0200","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1006\/abbi.1999.1646","article-title":"Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGE(2)","volume":"374","author":"Rockwell","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0205","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJMoa0801479","article-title":"Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma","volume":"359","author":"San Miguel","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/B978-0-12-386986-9.00002-8","article-title":"Monoclonal antibodies as novel neurotherapeutic agents in CNS injury and repair","volume":"102","author":"Sharma","year":"2012","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0215","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuro.2013.09.001","article-title":"Bortezomib alters microtubule polymerization and axonal transport in rat dorsal root ganglion neurons","volume":"39C","author":"Staff","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0220","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/(SICI)1097-4598(199903)22:3<329::AID-MUS5>3.0.CO;2-8","article-title":"Physiological and immunohistochemical characterization of cisplatin-induced neuropathy in mice","volume":"22","author":"Verdu","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0225","doi-asserted-by":"crossref","first-page":"e12941","DOI":"10.1371\/journal.pone.0012941","article-title":"Evaluation of an anti-tumor necrosis factor therapeutic in a mouse model of Niemann\u2013Pick C liver disease","volume":"5","author":"Vincent","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0230","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1126\/science.281.5383.1680","article-title":"NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation","volume":"281","author":"Wang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0235","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1038\/bcj.2013.47","article-title":"Phytohemagglutinin-induced IL2 mRNA in whole blood can predict bortezomib-induced peripheral neuropathy for multiple myeloma patients","volume":"3","author":"Watanabe","year":"2013","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0240","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/CEJ.0b013e3282b6fcff","article-title":"Antitumor necrosis factor-alpha therapy and potential cancer inhibition","volume":"17","author":"Williams","year":"2008","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0245","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.neuroscience.2011.10.010","article-title":"Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat","volume":"199","author":"Xiao","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2013.12.020_bb0250","doi-asserted-by":"crossref","first-page":"E844","DOI":"10.1152\/ajpendo.00029.2011","article-title":"Inactivation of TNF-alpha ameliorates diabetic neuropathy in mice","volume":"301","author":"Yamakawa","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.expneurol.2013.12.020_bb0255","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.expneurol.2012.08.023","article-title":"Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy","volume":"238","author":"Zheng","year":"2012","journal-title":"Exp. Neurol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488613003865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488613003865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T16:31:59Z","timestamp":1716395519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488613003865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":49,"alternative-id":["S0014488613003865"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2013.12.020","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with anti-TNF alpha protects against the neuropathy induced by the proteasome inhibitor bortezomib in a mouse model","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2013.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}